Floatz logo

RISEDRONIC ACID

Postmenopausal Osteoporosis

University of NebraskaSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Postmenopausal Osteoporosis cohort.

Asset / SponsorPhaseRating
Liuwei Dihuang Pills
xuhuijuan
Phase 2CCC
Calcium
University of Nebraska
N/AD

Same molecule, other indications

RISEDRONIC ACID is also rated in:

osteoporosisDormant
BBB
Indicative ·
79 / 100
View asset →
bone resorption diseaseDormant
BBB
Indicative ·
76 / 100
View asset →
bone fractureDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →